期刊文献+

氟桂利嗪对偏头痛模型大鼠中脑导水管周围灰质区NF-κB蛋白表达的影响 被引量:21

THE INFLUENCE OF NF-κB PROTEIN EXPRESSION IN THE PERIAQUEDUNCTAL GRAY MATTER INDUCED BY FLUNARIZINE IN RAT MIGRAINE MODEL
下载PDF
导出
摘要 目的:探讨氟桂利嗪治疗偏头痛的可能作用机制。方法:应用大鼠电刺激偏头痛模型,观察给予氟桂利嗪后中脑导水管周围灰质NF-κB蛋白表达的变化。结果:空白组、假手术组、电刺激组,氟桂利嗪组、生理盐水对照组每张切片的NF-κB阳性神经元数分别为111.7±15.7、112.9±10.7、508.7±30.8、209.2±18.5、502.7±33.1。结论:电刺激大鼠上矢状窦区硬脑膜后,在中脑导水管周围灰质区出现了NF-κB细胞的激活,氟桂利嗪使其表达降低。 Objective: To investigate the possible mechanism of action of the flunarizine in treating migraine.Method: Migraine model of electrical stimulation is applied to observe the level of NF-κB expression in the periaqueductal gray matter following administration of flunarizine in rats.Result: The numbers of NF-κB immunoreactive positive neurons was 209.2±18.5 in flunarizine group,502.7±33.1 in normal saline group,508.7±30.8 in stimulated group,and 111.7±15.7 and 112.9±10.7 in blank group and control group.Conclusion: The NF-κB positive neurons were activated in the periaqueductal gray in response to electric stimulation of the dura mater near the superior sagittal sinus.The expression of NF-κB protein could be suppressed by flunarizine.
出处 《中国疼痛医学杂志》 CAS CSCD 2011年第2期107-110,共4页 Chinese Journal of Pain Medicine
基金 国家自然科学基金资助项目(30570264)
关键词 偏头痛 上矢状窦 中脑导水管周围灰质 NF-ΚB蛋白 氟桂利嗪 Migraine Superior sagittal sinus Periaqueductal gray NF-κB Flunarizine
  • 相关文献

参考文献14

  • 1Schoonbroodt S,Piette J.Oxidative stress interference with the nuclear factor-kappa B activation pathways.Biochem Pharmacol,2000,60:1075 - 1083.
  • 2Bowie A,O'Neill LA.The interleukin-1 receptor/ Toll-like receptor supenamily:signal generators for pro-inflammatory interleukins and microbial products.J Leukocyte Biology,2000,67:508-514.
  • 3Burns K,Clatworthy J,Martin L,et al.Tollip,a new component of the IL-1RI pathway,links IRAK to the IL-1 receptor.Nat Cell Biology,2000,2:346-351.
  • 4Groenewegen WA,Knight DW,Heptinstall S.Compounds extracted from feverfew that have antisecretory activity contain an alpha-methylene buty-rolactone unit.J Pharm Pharmacol,1986,38:709-712.
  • 5Zingarelli B,Hake PW,Yang Z,et al.Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappa B and AP-1 activation and enhances myocardial damage.FASEB J,2002,16:327 -342.
  • 6Denys A,UdalovaI A,Smith C,et al.Evidence for adual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages.J Immunol,2002,168:4837-4845.
  • 7Umezawa K,Ariga A,Matsumoto N.Naturally occurring and synthetic inhibitors of NF-ΚB functions.Anti-Cancer Drug Design,2000,15:239 - 244.
  • 8Morishita R,Higaki J,Tomita N,et al.Application of transcription factor" decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.Circulation,1998,82:1023-1028.
  • 9Morishita R,Aoki M,Kaneda Y.Decoy oligode-oxynucleotides as novel cardiovascular drugs for cardiovascular disease.Ann N Y Acad Sci,2001,947:294-301.
  • 10Manninen HI,Makine nK.Gene therapy techniques for peripheral arterial disease.Cardiovasc Intervent Radiol,2002,25:98-108.

同被引文献294

引证文献21

二级引证文献252

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部